Replies to post #30167 on Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

I believe mallinckrodt called their man into FDA and asked for a check on ipci Andas and they went for the most likely to be approved in a reasonable time.

My guess is they partnered the 3 with the greatest or reasonable money potential... the 3 partnered only have about a half dozen manufacturers competing, and market value is not likely to shrink below 50% to 60% once genericized.

They could have had Keppra but not that big a market, and Gluco which has a $ billion + market but also has about 20 competitors.

I think Ranexa has promise... let's hope it received a 10 month GDUFA date.